Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development Nov 8, 2018
Aurinia Pharmaceuticals to Release Third Quarter Financial Results and General Business Updates on November 8, 2018 Oct 25, 2018
Aurinia Completes Enrollment of AURORA, its Phase 3 Clinical Trial for the Treatment of Lupus Nephritis Sep 25, 2018
Aurinia Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018 Aug 28, 2018
Aurinia Pharmaceuticals to Release Second Quarter 2018 Financial Results on August 9, 2018 Jul 30, 2018
Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome Jul 11, 2018
